142 related items for PubMed ID: 3632253
1. Dexamethasone suppression test and plasma dexamethasone levels in bulimia.
Walsh BT, Lo ES, Cooper T, Lindy DC, Roose SP, Gladis M, Glassman AH.
Arch Gen Psychiatry; 1987 Sep; 44(9):797-800. PubMed ID: 3632253
[Abstract] [Full Text] [Related]
2. Disturbances in the hypothalamo-pituitary-adrenal and other neuroendocrine axes in bulimia.
Fichter MM, Pirke KM, Pöllinger J, Wolfram G, Brunner E.
Biol Psychiatry; 1990 May 01; 27(9):1021-37. PubMed ID: 2110485
[Abstract] [Full Text] [Related]
3. Cortisol responses on the dexamethasone suppression test among women with Bulimia-spectrum eating disorders: associations with clinical symptoms.
Bruce KR, Steiger H, Israël M, Groleau P, Ng Ying Kin NM, Ouellette AS, Sycz L, Badawi G.
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug 07; 38(2):241-6. PubMed ID: 22575215
[Abstract] [Full Text] [Related]
4. Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia.
Walsh BT, Roose SP, Katz JL, Dyrenfurth I, Wright L, Vande Wiele R, Glassman AH.
Psychoneuroendocrinology; 1987 Aug 07; 12(2):131-40. PubMed ID: 3037583
[Abstract] [Full Text] [Related]
5. DST in bulimia without endogenous depression.
Levy AB, Dixon KN.
Biol Psychiatry; 1987 Jun 07; 22(6):783-6. PubMed ID: 3593818
[No Abstract] [Full Text] [Related]
6. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
Hudson JI, Pope HG, Jonas JM, Laffer PS, Hudson MS, Melby JC.
Psychiatry Res; 1983 Feb 07; 8(2):111-7. PubMed ID: 6574529
[Abstract] [Full Text] [Related]
7. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
Arana GW, Wilens TE, Baldessarini RJ.
Psychoneuroendocrinology; 1985 Feb 07; 10(1):49-60. PubMed ID: 4001277
[Abstract] [Full Text] [Related]
8. The dexamethasone suppression test for Japanese with eating disorders.
Fukata S, Tamai H, Takaichi Y, Mori K, Matsubayashi S, Nakagawa T.
Jpn J Psychiatry Neurol; 1988 Mar 07; 42(1):59-64. PubMed ID: 3398356
[Abstract] [Full Text] [Related]
9. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
Arch Gen Psychiatry; 1987 Sep 07; 44(9):790-5. PubMed ID: 3632252
[Abstract] [Full Text] [Related]
10. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels.
Holsboer-Trachsler E, Buol C, Wiedemann K, Holsboer F.
Acta Psychiatr Scand; 1987 Jun 07; 75(6):608-13. PubMed ID: 3618283
[Abstract] [Full Text] [Related]
11. Dexamethasone suppression testing in chronic renal failure: pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis.
Workman RJ, Vaughn WK, Stone WJ.
J Clin Endocrinol Metab; 1986 Sep 07; 63(3):741-6. PubMed ID: 3734041
[Abstract] [Full Text] [Related]
12. The dexamethasone suppression test in depressed retarded adults: preliminary findings.
Beckwith BE, Parker L, Pawlarczyk D, Couk DI, Schumacher KS, Yearwood K.
Biol Psychiatry; 1985 Aug 07; 20(8):825-31. PubMed ID: 4027299
[Abstract] [Full Text] [Related]
13. Reproducibility of the low dose dexamethasone suppression test: comparison between direct plasma and salivary cortisol assays.
Reynolds RM, Bendall HE, Whorwood CB, Wood PJ, Walker BR, Phillips DI.
Clin Endocrinol (Oxf); 1998 Sep 07; 49(3):307-10. PubMed ID: 9861320
[Abstract] [Full Text] [Related]
14. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
Jakovljević M, Mück-Seler D, Pivac N, Crncević Z.
Neuropsychobiology; 1998 Sep 07; 37(3):142-5. PubMed ID: 9597670
[Abstract] [Full Text] [Related]
15. Dexamethasone suppression test and sleep deprivation in endogenous depression.
Kuhs H.
J Affect Disord; 1985 Sep 07; 9(2):121-6. PubMed ID: 2932484
[Abstract] [Full Text] [Related]
16. Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma.
Lane SJ, Atkinson BA, Swaminathan R, Lee TH.
Am J Respir Crit Care Med; 1996 Feb 07; 153(2):557-60. PubMed ID: 8564097
[Abstract] [Full Text] [Related]
17. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients.
Mück-Seler D, Pivac N, Jakovljević M, Brzović Z.
Biol Psychiatry; 1999 Jun 01; 45(11):1433-9. PubMed ID: 10356625
[Abstract] [Full Text] [Related]
18. Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa.
Neudeck P, Jacoby GE, Florin I.
Physiol Behav; 2001 Jan 01; 72(1-2):93-8. PubMed ID: 11239985
[Abstract] [Full Text] [Related]
19. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.
Arch Gen Psychiatry; 1984 Mar 01; 41(3):257-67. PubMed ID: 6367690
[Abstract] [Full Text] [Related]
20. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
Rybakowski J, Linka M, Matkowski K, Kanarkowski R.
Psychiatr Pol; 1991 Mar 01; 25(5):9-15. PubMed ID: 1821997
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
